Adage Capital Partners’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56M | Buy |
1,290,464
+563,464
| +78% | +$24.5M | 0.09% | 210 |
|
|
2025
Q1 | $27.2M | Buy |
727,000
+486,800
| +203% | +$18.2M | 0.05% | 348 |
|
|
2024
Q4 | $10.9M | Buy |
+240,200
| New | +$10.9M | 0.02% | 583 |
|
|
2024
Q3 | – | Sell |
-50,000
| Closed | -$1.97M | – | 871 |
|
|
2024
Q2 | $1.97M | Sell |
50,000
-125,000
| -71% | -$4.92M | ﹤0.01% | 780 |
|
|
2024
Q1 | $11.6M | Sell |
175,000
-350,000
| -67% | -$23.3M | 0.02% | 570 |
|
|
2023
Q4 | $14.7M | Buy |
525,000
+150,000
| +40% | +$4.19M | 0.03% | 512 |
|
|
2023
Q3 | $7.99M | Buy |
+375,000
| New | +$7.99M | 0.02% | 608 |
|